|
| | Publication Year | Title | Author(s) |
| 741 | 30-Jan-2023 | A review of diffusion-weighted magnetic resonance imaging in head and neck cancer patients for treatment evaluation and prediction of radiation-induced xerostomia. | Ermongkonchai, Tai; Khor, Richard ; Wada, Morikatsu ; Lau, Eddie ; Xing, Daniel T ; Ng, Sweet Ping |
| 742 | 21-Nov-2014 | RHOA inactivation enhances Wnt signalling and promotes colorectal cancer. | Rodrigues, Paulo; Macaya, Irati; Bazzocco, Sarah; Mazzolini, Rocco; Andretta, Elena; Dopeso, Higinio; Mateo-Lozano, Silvia; Bilić, Josipa; Cartón-García, Fernando; Nieto, Rocio; Suárez-López, Lucia; Afonso, Elsa; Landolfi, Stefania; Hernandez-Losa, Javier; Kobayashi, Kazuto; Cajal, Santiago Ramón Y; Tabernero, Josep; Tebbutt, Niall C ; Mariadason, John M ; Schwartz, Simo; Arango, Diego |
| 743 | Jun-2019 | Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial. | Tapia Rico, Gonzalo; Price, Timothy; Tebbutt, Niall C ; Hardingham, Jennifer; Lee, Chee; Buizen, Luke; Wilson, Kate; Gebski, Val; Townsend, Amanda |
| 744 | Nov-2017 | Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised,
double-blind, placebo-controlled, phase 3 trial. | Catenacci, Daniel V T; Tebbutt, Niall C ; Davidenko, Irina; Murad, André M; Al-Batran, Salah-Eddin; Ilson, David H; Tjulandin, Sergei; Gotovkin, Evengy; Karaszewska, Boguslawa; Bondarenko, Igor; Tejani, Mohamedtaki A; Udrea, Anghel A; Tehfe, Mustapha; De Vita, Ferdinando; Turkington, Cheryl; Tang, Rui; Ang, Agnes; Zhang, Yilong; Hoang, Tien; Sidhu, Roger; Cunningham, David |
| 745 | 27-Jan-2011 | Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. | Tebbutt, Niall C ; Murphy, F; Zannino, D; Wilson, K; Cummins, M M; Abdi, E; Strickland, A H; Lowenthal, R M; Marx, G; Karapetis, C; Shannon, J; Goldstein, David B; Nayagam, S S; Blum, R; Chantrill, L; Simes, R J; Price, Timothy J |
| 746 | Oct-2018 | Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer. | Hamid, Anis A; Willson, Kaspar; Vincent, Andrew D; Tamjid, Babak ; Lee, Margaret; Bergin, Alice; Gan, Chun; Campbell, Ainsley ; Stewart, Josephine; Pezaro, Carmel; Tran, Ben; Weickhardt, Andrew J |
| 747 | 1-Aug-2016 | Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial | Gleeson, Mary; Hawkes, Eliza A ; Cunningham, David; Chadwick, Nick; Counsell, Nicholas; Lawrie, Anthony; Jack, Andrew; Smith, Paul; Mouncey, Paul; Pocock, Christopher; Ardeshna, Kirit M; Radford, John; McMillan, Andrew; Davies, John; Turner, Deborah; Kruger, Anton; Johnson, Peter WM; Gambell, Joanna; Linch, David |
| 748 | Apr-2021 | The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma. | Arulananda, Surein; Lee, Erinna F; Fairlie, Walter Douglas ; John, Thomas |
| 749 | 26-Nov-2020 | The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma. | Arulananda, Surein; Lee, Erinna F; Fairlie, W Douglas; John, Thomas |
| 750 | 29-Jul-2014 | The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials. | Segelov, E; Chan, David L; Shapiro, J; Price, Timothy J; Karapetis, C S; Tebbutt, Niall C ; Pavlakis, N |
| 751 | 23-Jul-2013 | The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer. | John, Thomas ; Starmans, Maud H W; Chen, Yao-Tseng; Russell, Prudence A; Barnett, Stephen A ; White, Shane C; Mitchell, Paul L R ; Walkiewicz, Marzena; Azad, Arun A; Lambin, Philippe; Tsao, Ming-Sound; Deb, Siddhartha; Altorki, Nasser; Wright, Gavin; Knight, Simon R ; Boutros, Paul C; Cebon, Jonathan S |
| 752 | Sep-2021 | The role of illness perceptions and exercise beliefs in exercise engagement during treatment for cancer. | Cole, Siân F; Skaczkowski, Gemma ; Wilson, Carlene J |
| 753 | 1-Apr-2015 | Role of immunotherapy in lung cancer: Preliminary results of new vaccines and immune checkpoint inhibitors. | John, Thomas |
| 754 | 10-Nov-2007 | Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions. | Lee, S T; Tan, T; Poon, A M T; Toh, H B; Gill, S; Berlangieri, Salvatore U ; Kraft, E; Byrne, Amanda J; Pathmaraj, K ; O'Keefe, Graeme J; Tebbutt, Niall C ; Scott, Andrew M |
| 755 | Aug-2021 | Role of Radiation Therapy in Gastric Cancer. | Ng, Sweet Ping ; Leong, Trevor |
| 756 | 2018 | Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission. | Hawkes, Eliza A ; Loh, Zoe ; Estacio, Ortis; Chong, Geoffrey ; Ha, Francis J; Gilbertson, Michael; Grigg, Andrew P |
| 757 | Nov-2020 | Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression. | Piercey, Oliver A; Loh, Zoe ; Chan, Joanna; Chong, Geoffrey ; Grigg, Andrew P ; Cheema, Steven ; Gill, Gurjot; Whybird, Matthew; Cushion, Tania; Hawkes, Eliza A |
| 758 | 4-Aug-2021 | Safe administration of obinutuzumab to rituximab-intolerant patients. | Manos, Kate ; Grigg, Andrew P |
| 759 | 25-Apr-2023 | Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma. | Younes, Anas; Burke, John M; Cheson, Bruce D; Diefenbach, Catherine; Ferrari, Silvia; Hahn, Uwe; Hawkes, Eliza A ; Khan, Cyrus; Lossos, Izidore S; Musuraca, Gerardo; Tani, Monica; Vitolo, Umberto; Yuen, Sam L S; Raval, Aparna; Shivhare, Mahesh; Nielsen, Tina G; Sellam, Gila; Sharman, Jeff P |
| 760 | 2019 | Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial. | Lassman, Andrew B; van den Bent, Martin J; Gan, Hui K ; Reardon, David A; Kumthekar, Priya; Butowski, Nicholas; Lwin, Zarnie; Mikkelsen, Tom; Nabors, Louis B; Papadopoulos, Kyriakos P; Penas-Prado, Marta; Simes, John; Wheeler, Helen; Walbert, Tobias; Scott, Andrew M ; Gomez, Erica; Lee, Ho-Jin; Roberts-Rapp, Lisa; Xiong, Hao; Ansell, Peter J; Bain, Earle; Holen, Kyle D; Maag, David; Merrell, Ryan |
